Natriuretic Peptides in the Diagnosis and Management of Acute Heart Failure

Heart Failure Clinics

Volumn 5, Issue 4, 2009, Pages 489-500

  Mohammed, Asim A ^a   Januzzi Jr , James L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Age; Chronic kidney disease; Heart failure; Multi marking panels; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CARDIAC AGENT; GALECTIN 3; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C;

ACUTE HEART FAILURE; BODY MASS; CHRONIC KIDNEY DISEASE; CORONARY ARTERY DISEASE; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DYSPNEA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; LUNG EMBOLISM; PATIENT MONITORING; PROGNOSIS; REVIEW; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ACUTE DISEASE; ALGORITHMS; BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDES;

EID: 67650694489     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2009.04.007     Document Type: Review

References (48)

1. Fang J., Mensah G.A., Croft J.B., et al. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 52 6 (2008) 428-434
2. de Bold A.J., Borenstein H.B., Veress A.T., et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28 (1981) 89-94
3. Galasko G.I., Lahiri A., Barnes S.C., et al. What is the normal range for N-terminal probrain natriuretic peptide? How well does this normal range screen for cardiovascular disease?. Eur Heart J 26 21 (2005) 2269-2276
4. Chang A.Y., Abdullah S.M., Jain T., et al. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol 49 1 (2007) 109-116
5. Das S.R., Drazner M.H., Dries D.L., et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 112 14 (2005) 2163-2168
6. Krauser D.G., Lloyd-Jones D.M., Chae C.U., et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 149 4 (2005) 744-750
7. McCord J., Mundy B.J., Hudson M.P., et al. Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med 164 20 (2004) 2247-2252
8. Schou M., Gustafsson F., Kjaer A., et al. Long-term clinical variation of NT pro-BNP in stable chronic heart failure patients. Eur Heart J 28 2 (2007) 177-182
9. Wu A.H., Smith A., Wieczorek S., et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 92 5 (2003) 628-631
10. Bruins S., Fokkema M.R., Romer J.W., et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal pro-BNP in patients with stable chronic heart failure. Clin Chem 50 11 (2004) 2052-2058
11. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 12 (2005) e154-e235
12. Arnold J.M., Liu P., Demers C., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 22 1 (2006) 23-45
13. Tang W.H., Francis G.S., Morrow D.A., et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. Circulation 116 5 (2007) e99-109
14. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 3 (2002) 161-167
15. Cowie M.R., Struthers A.D., Wood D.A., et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 9088 (1997) 1349-1353
16. McCullough P.A., Duc P., Omland T., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41 3 (2003) 571-579
17. Bayes-Genis A., Santalo-Bel M., Zapico-Muniz E., et al. N-terminal probrain natriuretic peptide (NT pro-BNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 6 3 (2004) 301-308
18. Lainchbury J.G., Campbell E., Frampton C.M., et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42 4 (2003) 728-735
19. Mueller T., Gegenhuber A., Poelz W., et al. Head-to-head comparison of the diagnostic utility of BNP and NT pro-BNP in symptomatic and asymptomatic structural heart disease. Clin Chim Acta 341 (2004) 41-48
20. Januzzi Jr. J.L., Camargo C.A., Anwaruddin S., et al. The N-terminal Pro-BNP Investigation of Dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 8 (2005) 948-954
21. Mueller C., Laule-Kilian K., Schindler C., et al. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med 166 10 (2006) 1081-1087
22. Moe G.W., Howlett J., Januzzi J.L., et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation 115 24 (2007) 3103-3110
23. Siebert U., Januzzi Jr. J.L., Beinfeld M.T., et al. Cost-effectiveness of using N-terminal probrain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department. Am J Cardiol 98 6 (2006) 800-805
24. Januzzi J.L., van Kimmenade R., Lainchbury J., et al. NT pro-BNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27 3 (2006) 330-337
25. Maisel A.S., McCord J., Nowak R.M., et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41 11 (2003) 2010-2017
26. van Kimmenade R.R.J., Pinto Y.M., Bayes-Genis A., et al. Usefulness of intermediate amino-terminal probrain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure. Am J Cardiol 98 3 (2006) 386-390
27. van Kimmenade R., Januzzi Jr. J.L., Baggish A.L., et al. Amino-terminal pro-brain natriuretic peptide, renal function and outcomes in acute heart failure; redefining the cardio-renal interaction?. J Am Coll Cardiol 48 8 (2006) 1621-1627
28. Toth M., Vuorinen K.H., Vuolteenaho O., et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 266 (1994) H1572-H1580
29. Marumoto K., Hamada M., and Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond) 88 5 (1995) 551-556
30. Kyriakides Z.S., Markianos M., Michalis L., et al. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol 23 4 (2000) 285-288
31. Binder L., Pieske B., Olschewski M., et al. N-terminal probrain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 112 11 (2005) 1573-1579
32. Maisel A., Hollander J.E., Guss D., et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 44 6 (2004) 1328-1333
33. O'Donoghue M., Chen A., Baggish A.L., et al. The effects of ejection fraction on N-terminal pro-BNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail 11 Suppl 5 (2005) S9-14
34. Kazanegra R., Cheng V., Garcia A., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7 1 (2001) 21-29
35. Knebel F., Schimke I., Pliet K., et al. NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation. J Card Fail 11 Suppl 5 (2005) S38-S41
36. Cioffi G., Tarantini L., Stefenelli C., et al. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function. J Card Fail 12 8 (2006) 608-615
37. Di Somma S., Magrini L., Mazzone M., et al. Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure. Am J Emerg Med 25 3 (2007) 335-339
38. Logeart D., Thabut G., Jourdain P., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 4 (2004) 635-641
39. Bettencourt P., Azevedo A., Pimenta J., et al. N-terminal probrain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 15 (2004) 2168-2174
40. Heywood J.T., Fonarow G.C., Costanzo M.R., et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13 6 (2007) 422-430
41. van Kimmenade R.R., Pinto Y., and Januzzi Jr. J.L. When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the cardio-renal syndrome?. Eur Heart J 28 24 (2007) 2960-2961
42. Sakhuja R., Green S., Oestreicher E.M., et al. Amino terminal probrain natriuretic peptide, brain natriuretic peptide, and troponin T for prediction of mortality in acute heart failure. Clin Chem 53 3 (2007) 412-420
43. Baggish A.L., van Kimmenade R., Bayes-Genis A., et al. Hemoglobin and N-terminal probrain natriuretic peptide: independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) study. Clin Chim Acta 381 2 (2007) 145-150
44. Rehman S., Lloyd-Jones D.M., Martinez-Rumayor A., et al. Inflammatory markers, amino terminal probrain natriuretic peptide, and mortality risk in dyspneic patients. Am J Clin Pathol 130 2 (2008) 305-311
45. van Kimmenade R.R., Januzzi Jr. J.L., Ellinor P.T., et al. Utility of amino terminal probrain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48 6 (2006) 1217-1224
46. Januzzi Jr. J.L., Peacock W.F., Maisel A.S., et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (ProBrain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 50 7 (2007) 607-613
47. Rehman S.U., Mueller T., and Januzzi Jr. J.L. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 52 18 (2008) 1458-1465
48. Rehman S.U., Martinez-Rumayor A., Mueller T., et al. Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Clin Chim Acta 392 (2008) 41-45